Lifeng Wang
-
- Pancreatic and Hepatic Oncology Research 4
- Cancer Cells and Metastasis 3
- Peptidase Inhibition and Analysis 3
-
- Genetic factors in colorectal cancer 3
-
- Epigenetics and DNA Methylation 4
- Chromatin Remodeling and Cancer 2
-
- Gastric Cancer Management and Outcomes 5
-
- Glioma Diagnosis and Treatment 4
- Journals
- Cancer Research (1 paper)Scientific Reports (1 paper)Journal of Cellular Physiology (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Lifeng Wang
32 papers receiving 500 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 144
- Oncology 177
- Pathology and Forensic Medicine 72
- Molecular Biology 244
- Pulmonary and Respiratory Medicine 110
Countries citing papers authored by Lifeng Wang
This map shows the geographic impact of Lifeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lifeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lifeng Wang more than expected).
Fields of papers citing papers by Lifeng Wang
This network shows the impact of papers produced by Lifeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lifeng Wang. The network helps show where Lifeng Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lifeng Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 2 | |
| 3 | 2023 | 2 | |
| 4 | 2022 | 1 | |
| 5 | 2022 | 3 | |
| 6 | 2022 | 8 | |
| 7 | 2021 | 4 | |
| 8 | 2021 | 6 | |
| 9 | 2019 | 0 | |
| 10 | 2019 | 18 | |
| 11 | 2018 | 38 | |
| 12 | 2017 | 23 | |
| 13 | 2017 | 2 | |
| 14 | 2016 | 13 | |
| 15 | 2016 | 14 | |
| 16 | 2014 | 11 | |
| 17 | 2012 | 29 | |
| 18 | 2012 | 22 | |
| 19 | 2011 | 10 | |
| 20 | 2007 | 33 |
About Lifeng Wang
Lifeng Wang is a scholar working on Oncology, Genetics and Gastroenterology, having authored 34 papers that have together received 504 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Glioma Diagnosis and Treatment (4 papers), Pancreatic and Hepatic Oncology Research (4 papers), Epigenetics and DNA Methylation (4 papers), Cancer Cells and Metastasis (3 papers), Peptidase Inhibition and Analysis (3 papers), Genetic factors in colorectal cancer (3 papers) and Chromatin Remodeling and Cancer (2 papers). The work is most often cited by research in Cancer Research (144 citations), Oncology (177 citations) and Pathology and Forensic Medicine (72 citations). Lifeng Wang has collaborated with scholars based in China, United States and France. Frequent co-authors include Ruifen Wang, Wenbin Guan, Hongmei Wu, Wenguang Sun, Mawei Jiang, Meng Qiao, Xiaojun Yuan, Jia Liu, Leizhen Zheng and Meiling Zhu. Their work appears in journals such as Cancer Research, Scientific Reports and Journal of Cellular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.